- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05781464
Effect of Prolonged Slow Expiration Technique on Blood Gases Among Pneumatic Neonates
Effect of Prolonged Slow Expiration Technique on Blood Gases Among Neonates With Pneumonia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pneumonia is an infective lung condition that is one of the most common risk factors for neonatal death. Pulmonary infections, most common caused by anaerobic bacterial infection, result in the accumulation of pus in the pleural cavity. Preterms, neonates with respiratory infections, and underdeveloped lungs all require the use of a prolonged slow expiration technique.
Prolonged slow expiration technique is the only chest clearance technique that provides both effective clearance and a soothing effect. Another recommendation for this technique is lack of application of emerging techniques of respiratory physiotherapy. Although the technique is effective, it is rarely in practice over the conventional methods of chest physiotherapy.
During prolonged slow expiration, intrathoracic pressure gradually rises due to thoracoabdominal compression, preventing bronchial collapse and flow disruption that occurs during forced expirations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Giza, Egypt
- Faculty of Physical Therapy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age since birth till 2 months
- Clinical findings of pneumonia: tachypnea, chest recession, fever, cyanosis and cough
- Radiological diagnosis of pneumonia (x-ray): lober or segmental consolidation, nodular or coarse patchy infiltration, diffuse haziness and air bronchogram.
- Neonates on oxygen therapy.
Exclusion Criteria:
- Neonates with congenital cardiopathy.
- Neonates with surgical incision in thorax or abdomen.
- Neonates with neurological intervention.
- Neonates with obstruction of upper air way.
- Neonates with gastroesophageal reflux and laryngeal affection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Traditional chest physiotherapy
This group receives traditional chest physiotherapy that include postural drainage, percussion and vibration ( manually or by a vibrator) in each session which is twice daily from admission to neonatal intensive care unit till discharge
|
Postural drainage: the patient is positioned in postural drainage so that gravity had the maximum effect on the lung segment that needed to be drained, all lung zones are emphasised in positional initiatives for babies. Percussion is the rhythmic striking of the chest wall with cupped hands for 1 to 2 minutes at a time. Vibration is performed by placing fingers on the chest wall over the segment being drained and isometrically contracting the forearm and hand muscles to produce a vibratory motion. Vibration is accomplished either through manual vibratory motion of the therapist's fingers on the infant's chest wall or through the use of a mechanical vibrator ( Foreo vibrator).
Other Names:
|
|
Active Comparator: Prolonged slow expiration technique and traditional chest physiotherapy
This group receives traditional chest physiotherapy that include postural drainage, percussion and vibration ( manually or by a vibrator) plus prolonged slow expiration technique in each session which is twice daily from admission in neonatal intensive care unit till discharge.
|
Postural drainage: the patient is positioned in postural drainage so that gravity had the maximum effect on the lung segment that needed to be drained, all lung zones are emphasised in positional initiatives for babies. Percussion is the rhythmic striking of the chest wall with cupped hands for 1 to 2 minutes at a time. Vibration is performed by placing fingers on the chest wall over the segment being drained and isometrically contracting the forearm and hand muscles to produce a vibratory motion. Vibration is accomplished either through manual vibratory motion of the therapist's fingers on the infant's chest wall or through the use of a mechanical vibrator ( Foreo vibrator).
Other Names:
The therapist places one hand on the thorax below the suprasternal notch and the other hand over the upper abdomen while the neonate is supine.
Both hands will have hypothenar contact with the thorax and abdomen.
At the end of the expiratory phase, the therapist places a compression force with both hands.
Compression at the end of expiration with hypothenar eminence is kept for 2 or 3 breathing cycles.
This technique is repeated several times, with a rest time between applications of about 5 or 10 spontaneous breaths.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in arterial oxygen saturation (Sao2)
Time Frame: Change from Baseline SaO2 at 9 days
|
Arterial oxygen saturation is assessed by standardized international monitor and measured by %
|
Change from Baseline SaO2 at 9 days
|
|
Change in systolic and diastolic blood pressure
Time Frame: Change from baseline systolic and diastolic blood pressure at 9 days
|
Systolic and diastolic blood pressure are assessed by standardized international monitor and measured by millimeters of mercury ( mmHg)
|
Change from baseline systolic and diastolic blood pressure at 9 days
|
|
Change in heart rate (HR)
Time Frame: Change from baseline HR at 9 days
|
Heart rate is assessed by standardized international monitor and measured by beats per minute (BPM)
|
Change from baseline HR at 9 days
|
|
Change in temperature
Time Frame: Change from baseline temperature at 9 days
|
Temperature is assessed by thermometer and measured by degree(°)
|
Change from baseline temperature at 9 days
|
|
Change in power of hydrogen (PH)
Time Frame: Change from baseline PH at 9 days
|
PH is assessed by blood gases machine and it is a scale used to specify the acidity or basicity of blood
|
Change from baseline PH at 9 days
|
|
Change in partial pressure of carbon dioxide (PaCO2)
Time Frame: Change from baseline PaCO2 at 9 days
|
PaCO2 is assessed by blood gases machine and measured by mmHg and it serves as a marker of sufficient alveolar ventilation within the lungs
|
Change from baseline PaCO2 at 9 days
|
|
Change in bicarbonate (HCO3)
Time Frame: Change from baseline HCO3 at 9 days
|
HCO3 is assessed by blood gases machine and measured by milliequivalents per litre (mEq/L) and it is used to detect electrolyte imbalance
|
Change from baseline HCO3 at 9 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Elham Salem, Cairo university
Publications and helpful links
General Publications
- Gomes EL, Postiaux G, Medeiros DR, Monteiro KK, Sampaio LM, Costa D. Chest physical therapy is effective in reducing the clinical score in bronchiolitis: randomized controlled trial. Rev Bras Fisioter. 2012 Jun;16(3):241-7. doi: 10.1590/s1413-35552012005000018. Epub 2012 Apr 12.
- Lievens L, Vandenplas Y, Vanlaethem S, Van Ginderdeuren F. Prolonged Slow Expiration Technique and Gastroesophageal Reflux in Infants Under the Age of 1 Year. Front Pediatr. 2021 Sep 8;9:722452. doi: 10.3389/fped.2021.722452. eCollection 2021.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NoP.T.REC/012/003676
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial PneumoniaChina
Clinical Trials on Traditional chest physiotherapy
-
Cairo UniversityCompleted
-
McCarious Nahad Aziz Abdelshaheed StephensCairo UniversityActive, not recruitingPost-COVID-19 Syndrome | Lung Fibrosis InterstitialEgypt
-
Universidade Federal de Sao CarlosCompletedLung Disease | Obesity, AbdominalBrazil
-
University of PecsCompletedOpen Heart Surgery PatientsHungary
-
Capital Medical UniversityNot yet recruiting
-
NHS LothianCompleted
-
Cairo UniversityCompletedCough | Mechanical Ventilation Complication | Intensive Care Unit Acquired Weakness | Ineffective Airway Clearance | Diaphragm IssuesEgypt
-
Isra UniversityCompleted
-
Bezmialem Vakif UniversityCompleted
-
Hospital Clinic of BarcelonaSociedad Española de Neumología y Cirugía TorácicaUnknownNon-cystic Fibrosis Bronchiectasis